Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Zampetti, A; Giurdanella, F; Manco, S; Linder, D; Gnarra, M; Guerriero, G; Feliciani, C.
Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment.
Dermatol Surg. 2013; 39(7): 974-980. Doi: 10.1111/dsu.12135 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Linder Michael Dennis
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Background Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by immunologic abnormalities, disseminated human papilloma virus infection, and early development of skin cancers. Acquired forms have been rarely reported and usually occur with immunosuppression. The therapeutic management of the acquired forms is not standardized, and several therapies have been tried, with variable outcomes. Objectives To provide updated clinical and experimental information on the treatment of acquired EV. Methods A Medline literature search was performed for relevant Medical Subject Heading terms, reviewing publications on strategies for management of acquired EV. We also report a case successfully treated using a combination of photodynamic therapy and oral retinoids. Conclusion Data from the literature show that a standardized approach to this condition is lacking; the combination treatment chosen in our case may be proposed because it led to an excellent clinical outcome and a long-lasting remission.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Oral -
Aminolevulinic Acid - administration & dosage Aminolevulinic Acid - analogs & derivatives
Combined Modality Therapy -
Diathermy -
Epidermodysplasia Verruciformis - immunology Epidermodysplasia Verruciformis - pathology Epidermodysplasia Verruciformis - therapy
Female -
Humans -
Immunocompromised Host -
Middle Aged -
Photochemotherapy -
Photosensitizing Agents - administration & dosage
Retinoids - administration & dosage
Treatment Outcome -

© Med Uni GrazImprint